@mmc_im OAC use was found to be associated with increased risk of hospitalization for bleeding but not associated with reduced risk of stroke in patients with Afib and ESRD in this retrospective cohort study. https://t.co/AzfAQTy4Lt
@eric_weinhandl @Roxytonin This paper? https://t.co/CBYiRkGH8A
末期腎不全+心房細動への抗凝固療法は難しい。血栓塞栓も予防できず。二次予防限定ならどうでしょうか。 https://t.co/utSJ36ltbd
In patients with end-stage renal disease and #AFib, anticoagulants appear to increase the risk for bleeding, a new report in @JACCJournals suggests. Read more: https://t.co/OfWMV9hbSR @YaleMed @YaleIMed @ericjvelazquez
RT @jvillacastin: Es un estudio observacional pero encuentran q en los enfermos con insuficiencia renal avanzada, los anticoagulantes orale…
RT @jvillacastin: Es un estudio observacional pero encuentran q en los enfermos con insuficiencia renal avanzada, los anticoagulantes orale…
RT @jvillacastin: Es un estudio observacional pero encuentran q en los enfermos con insuficiencia renal avanzada, los anticoagulantes orale…
Es un estudio observacional pero encuentran q en los enfermos con insuficiencia renal avanzada, los anticoagulantes orales no protegen tanto como se esperaría de los ICTUS y en cambio se asocian a más hospitalizaciones y a más hemorragias cerebrales https:
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
ここら辺は相変わらず悩ましいところですね。
【コホート研究】末期腎疾患の心房細動患者において、経口抗凝固薬の服用は、服用なしと比較して、脳卒中による入院または死亡のリスク減少と関連しなかったが、出血および頭蓋内出血による入院のリスク増加と関連した。 https://t.co/XoMk38yAkR
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease https://t.co/yHPDGJJBHd
RT @FH_Verbrugge: Another disappointing result for #anticoagulation in #ESRD with #AFib. What’s your strategy?
Another disappointing result for #anticoagulation in #ESRD with #AFib. What’s your strategy?
RT @JonPicciniSr: Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patien…
RT @JACCJournals: #AFib is common in end-stage renal disease (ESRD), but the impact of #cvCoag in #ESRD patients is uncertain. Dr. @JonPicc…
RT @JonPicciniSr: Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patien…
RT @JonPicciniSr: Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patien…
RT @JonPicciniSr: Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patien…
RT @JACCJournals: #AFib is common in end-stage renal disease (ESRD), but the impact of #cvCoag in #ESRD patients is uncertain. Dr. @JonPicc…
RT @JonPicciniSr: Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patien…
Great work by @sean_pokorney @MaierBlack and Anne Hellkamp. We need better stroke prevention options for our #afib patients with #ESRD - need a RCT of #LAAO @DukeHeartCenter @IslaaFoundation @DCRINews @HRSonline
#AFib is common in end-stage renal disease (ESRD), but the impact of #cvCoag in #ESRD patients is uncertain. Dr. @JonPicciniSr and @DukeHealth colleagues investigate in #JACC. https://t.co/G6dbE7y9Xi https://t.co/3lKQHaxfVC
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease | JACC: Journal of the American College of Cardiology https://t.co/9HiwNaDxKX
Congratulations and nicely done @MaierBlack
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
RT @MaierBlack: Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We ne…
Warfarin in ESRD patients with AF: increased hospitalization, bleeding, and ICH without reduction in ischemic stroke. We need a better solution. Time to study LAAO? https://t.co/kBq3snzxjR
RT @Office_j: 【末期腎不全を伴うAFへのOACは有用?/ JACC】 米国メディケア受給、AF合併EASD 8410例解析:36.2%がOAC服用。傾向スコアマッチ後、OAC服用で、非服用に比べ、脳卒中入院HRは1.00 [95%CI 0.23-1.35]、死亡…
RT @Office_j: 【末期腎不全を伴うAFへのOACは有用?/ JACC】 米国メディケア受給、AF合併EASD 8410例解析:36.2%がOAC服用。傾向スコアマッチ後、OAC服用で、非服用に比べ、脳卒中入院HRは1.00 [95%CI 0.23-1.35]、死亡…
RT @Office_j: 【末期腎不全を伴うAFへのOACは有用?/ JACC】 米国メディケア受給、AF合併EASD 8410例解析:36.2%がOAC服用。傾向スコアマッチ後、OAC服用で、非服用に比べ、脳卒中入院HRは1.00 [95%CI 0.23-1.35]、死亡…
【末期腎不全を伴うAFへのOACは有用?/ JACC】 米国メディケア受給、AF合併EASD 8410例解析:36.2%がOAC服用。傾向スコアマッチ後、OAC服用で、非服用に比べ、脳卒中入院HRは1.00 [95%CI 0.23-1.35]、死亡も1.02 [0.94-1.10]。一方、出血入院は1.26 [1.09-1.46]。 https://t.co/J0UL6nslXY https://t.co/oPKbTl9AsN